Clinical applications of bivalirudin in the cardiac catheterization laboratory.

about

Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?

P2860

Q38237936-52F0A3C4-89F4-4A44-B62C-9FEEE82E608F Q38645947-772151F1-FB5E-4305-A9FA-F1B09AEE796C

P2860

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

Item

http://www.wikidata.org/entity/Q37811622

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@en

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@nl

type

Item

label

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@en

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@nl

prefLabel

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@en

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@nl

P1476

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

@en

P2093

Ernst R Schwarz

http://www.w3.org/2001/XMLSchema#string

Keith A Thompson

http://www.w3.org/2001/XMLSchema#string

Kiran J Philip

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Bivalirudin for patients with acute coronary syndromes

Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

P304

140-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248410385682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21097669

http://www.w3.org/2001/XMLSchema#string

P921

catheterization

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

about

P2860

P2860

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921